9th Annual Biomarkers Congress

Cell Biology: National Institutes of Health

Total Score People Score Events Score
194 164 80
Date Event Presentation Speakers
May 13, 2014 Lipidomics Impact on Cell Biology, Inflammation and Metabolic Disease Lipidomics Impact on Cell Biology, Inflammation and Metabolic Disease Ian A. Blair,
July 21, 2013 54th Annual Short Course on Medical and Experimental Mammalian Genetics Monday, July 29 Genetics of Infectious Diseases Steven M. Holland
June 23, 2013 10th International Conference on Innate Immunity 10th International Conference on Innate Immunity Thomas A. Wynn
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Deborah Morrison
The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Curtis C. Harris
Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY W. Marston Linehan
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James H. DOROSHOW
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Louis M. Staudt
Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Mice with Conditional Deletion of NF-kappaB–Inducing Kinase (NIK) in Dendritic Cells Show Defective CD40-Dependent Antigen Cross-Priming of CD8+ T Cells C Austin
Short Talk: Commensal Microbiota Modulates the Innate Response to Cancer Immunotherapy and Chemotherapy Romina Silvana Goldszmid
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions Cynthia E. Dunbar
Trainee Simultaneous Didactic Sessions Cynthia E. Dunbar
November 12, 2012 International Conference on Clinical Microbiology & Microbial Genomics Track 5 : Diagnostics Zhi-Ming Zheng
May 7, 2012 Proteomics, Interactomes Single Cell Observation of Transcription and Implication for the Proteome Daniel R. Larson
April 15, 2012 28th IABCR/Breakthrough Breast Cancer Conference Hunting for novel metastasis genes Kent W. Hunter
March 25, 2012 ISA 2012 - XVI International Symposium on Atherosclerosis Concurrent Workshop 19 | Micro RNAs - A New Insight into Atherosclerosis | Bayside Auditorium A Kasey Vickers
January 25, 2012 Excellence in Rheumatology PARALLEL HALL 3 | HOW TO evaluate and treat Myositis Lisa Rider
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Day in Review Curtis C. Harris
Inflammation and cancer: Interweaving microRNA, innate immune, and p53 networks Curtis C. Harris
Concurrent Session 4 | Cancer Genetics Curtis C. Harris
November 15, 2011 Cosa 38th Annual Scientific Meeting Best of the Best Orals - Basic and Translational research David Goldstein
CONCURRENT SYMPOSIA | Renal Cell Carcinoma: Learning from the Community David Goldstein
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Development of clinical trials incorporating genomic signatures: Lessons learned Lisa M McShane
New paradigms for early-phase clinical trials James H. DOROSHOW
Educational Session 2 | Clinical Trial Paradigms in the Era of Novel Therapies James H. DOROSHOW
Preventing multiple types of cancer through HPV vaccination Douglas R LOWY
August 31, 2011 Strategies for Engineered Negligible Senescence, 5th Conference (SENS5) Zscan4 | a key to telomerase-independent telomere elongation? Minoru Ko
May 5, 2011 Sixth International Congress on Electron Tomography Session 9 | Future Technologies Sriram Subramaniam
March 27, 2011 Congress on Steroid Research Neonatal exposure to estrogens or environmental estrogens induces aberrant promoter methylation and expression of nucleosomal binding protein (Nsbp1) in later-life Mitchell Ho
March 27, 2011 Autophagy (D1) Workshop 1: Novel Techniques to Track Autophagy Jennifer Lippincott-Schwartz
Roles of Parkin and Pink1 in Mitophagy Richard J Youle
Mechanisms of Macroautophagic Selectivity Jennifer Lippincott-Schwartz
March 20, 2011 HIV Evolution, Genomics, and Pathogenesis (X7) Genetics of HIV Entry into the Nucleus Vineet N. KewalRamani
Identification and Characterization of T Memory Stem Cells in Humans and NHP: Implication for Vaccine Design Mario Roederer
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) Mucosal Biology (X5) | Short Talk: TLR Agonists and/or IL-15 Adjuvanted Mucosal SIV-Vaccine Prevented Gut CD4+ Memory T Cell Loss After SIVmac251-Challenge in Macaques Yong Jun Sui
Mucosal Biology (X5) | Is the Direct Targeting of the Mucosa Necessary for an HIV Vaccine? Genoveffa Franchini
Mucosal Biology (X5) | Ocular Immune Privilege, T Regulatory Cells and Autoimmunity Rachel Caspi
Vaccines Inducing Pathogen-Specific Lung Immunity | Requirements for Immunity Against Pneumonic Tularemia Catharine . M. Bosio
Vaccines Inducing Pathogen-Specific Lung Immunity | Local Immunity Induced by Live Attenuated Pandemic Influenza Vaccines Kanta Subbarao
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) LPS Promotes IL-35-Dependent Suppression of Allergen-Induced Airway Disease Donald N. Cook
The IL-13 Decoy Receptor Tightly Controls Pathogenic Th17 and Th2 Responses in the Mucosa Thomas A. Wynn
Viruses in Health and Disease | Short Talk: TLR Agonists and/or IL-15 Adjuvanted Mucosal SIV-Vaccine Prevented Gut CD4+ Memory T Cell Loss After SIVmac251-Challenge in Macaques Yong Jun Sui
Viruses in Health and Disease | Is the Direct Targeting of the Mucosa Necessary for an HIV Vaccine? Genoveffa Franchini
Control of Immune Responses in the Skin, Eye and Genital Tract | Ocular Immune Privilege, T Regulatory Cells and Autoimmunity Rachel Caspi
Immunity in Respiratory Tract (X6) | Requirements for Immunity Against Pneumonic Tularemia Catharine . M. Bosio
Immunity in Respiratory Tract (X6) | Local Immunity Induced by Live Attenuated Pandemic Influenza Vaccines Kanta Subbarao
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Re-Imagining the Ideal Antitumor T Cell Nicholas P. Restifo
Translating Immune Responses Toward and Into the Clinic (Joint) | TLRs in Vaccine Development Robert Seder
February 6, 2011 Salivary Glands & Exocrine Biology Cell and tissue dynamics Kenneth. M. Yamada
A role for the acto-myosin complex in regulated exocytosis revealed by intravital microscopy Roberto Weigert
MicroRNAs regulate proliferation and cell fate decisions Ivan T Rebustini
Exocrine Glycobiology Sarah M. Knox
Protein O-glycosylation in developmentally regulated cell adhesion and organogenesis Kelly TenHagen
MicroRNAs as biomarkers of inflammation and salivary gland dysfunction in Sjögren's syndrome Gabor G. Illei
A little bit nervous? Parasympathetic innervation regulates epithelial progenitor cells Sarah M. Knox
Physiological function of store-operated calcium channels in epithelia and other non-excitable cells James W Putney
Transfer of human aquaporin-1 cDNA to correct radiation-induced salivary hypofunction Ana Cotrim
January 9, 2011 NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses (A4) NK and NKT Cells in Viral Infection | Immunogenetic variation characterizing exceptional control of HIV Mary Carrington
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Statistical challenges in predictive and prognostic biomarker studies: How to avoid wasting your time and specimens Lisa M McShane
October 25, 2010 Macrophages and Inflammation Session III : By Thomas A. Wynn Thomas A. Wynn
October 12, 2010 Aquitaine Conferences on Neurosciences The "light side" of addiction Roy Wise
Neurobiology of relapse to drug use Yavin Shaham
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Targeting TGF-beta to suppress metastasis Lalage M. Wakefield
A LPA1 inhibitor that functions as a metastasis suppressor Jean-Claude A. Marshall
Plenary Session 6: Translational Targets II Patricia Steeg
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Retrospective Study, 1918 Pandemic Virus and 2009 H1N1: Lessons for POCT Jeffery K. Taubenberger
Exporting Cervical Cancer Prevention to the Developing World: The Promise and the Challenges Philip E Castle
July 7, 2010 WIN Symposium in personalized cancer medicine Keynote Lecture | Challenges in the development and validation of biomarker signatures for personalized medicine: Lisa M McShane
Phase II and III clinical trial design and endpoints in targeted therapy era-future goals and challenges. Giuseppe Giaccone
April 30, 2010 Retinal Ganglion Cells Genetic risk factors for ganglion cell loss in African populations J. Fielding Hejtmancik
April 28, 2010 Kinase Inhibitor Chemistry Targeting the Polo-Box Domain of Polo-Like Knase 1 (Plk1) Kyung S Lee
April 11, 2010 Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2) * Systems Biology of the Immune Response | Big Horn B Peter D. Crompton
* Inducing Optimal Protective Responses with Vaccines | Big Horn B Joanna Kubler Kielb
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Towards a More Efficient Protein Biomarker Development Process Henry Rodriguez
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Behavioral and Social Science Considerations for Clinical Research Chuen-Yen Lau
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Leveraging Resources to Advance Drug Development: A Consortium Model for Biomarkers Research Shawnmarie Mayrand-Chung
June 22, 2009 Collaborative Innovation in Biomedicine The Biomarkers Consortium David Wholley
January 6, 2009 Angiogenesis and Lymphangiogenesis in Cancer (A2) Tumor Angiogenesis, Inflammation and the Microenvironment J. Silvio Gutkind,
September 15, 2008 Optimizing Cell Culture Development Reconstructing Human Skin to Better Understand Melanoma Development and Progression Professor Meenhard Herlyn
June 11, 2008 6th ISSCR Annual Meeting Plenary Session V: Adult Stem Cell Physiology R McKay
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
April 20, 2008 PINEAL CELL BIOLOGY Discussion Horst Werner Korf
Discussion Martin Zatz
April 20, 2008 PINEAL CELL BIOLOGY The Global Nature of the Daily Rhythms in Rodent Pineal Gene Expression David C. Klein
Discussion Horst Werner Korf
April 13, 2008 Cell Biology of Virus Entry, Replication and Pathogenesis Keynote Address Bernard Moss
April 13, 2008 Cell Biology of Virus Entry, Replication and Pathogenesis Keynote Address Bernard Moss
Viral Disease and Pathogenesis Ted C. Pierson
April 6, 2008 Islet and Beta Cell Development and Transplantation Understanding and Controlling Autoimmunity David M. Harlan, Shira Y. Perl
Model Systems for Assessing Beta Cell Replacements Klaus Ulrich Pechhold
Moving Towards Clinical Application David M. Harlan
March 25, 2008 R&D Risk Mitigation Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
March 25, 2008 Preclinical Development Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 TRANSLATIONAL MEDICINE The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
RNA Amplification as an Essential Approach for Biomarker Discovery Ena Wang
Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 RNAi, MicroRNA, and Non-Coding RNA RNAi-Based Therapy Morten Lindow
March 25, 2008 CYTOKINE-BASED THERAPEUTICS CNS Inflammatory Diseases Charles E Egwuagu
March 24, 2008 Alzheimer's Disease APP Processing, Function, and Cell Biology of Neurodegeneration Burgos Patricia V
March 2, 2008 LIGAND RECOGNITION & MOLECULAR GATING KEYNOTE LECTURE Susan Buchanan
Activation and allostery in glutamate receptor ion channels: Insights from crystallographic and functional studies Mark L Mayer
FOLDING AND LIPID-PROTEIN INTERACTIONS Kenton J Swartz
VOLTAGE-GATED ION CHANNELS Mark L Mayer
Toxins interacting with paddle motifs in voltage-sensing proteins Kenton J Swartz
LIGAND RECOGNITION IN G-PROTEIN COUPLED RECEPTORS Reinhard Grisshammer
March 2, 2008 VIRAL VECTORS FOR GENE THERAPY, THE SCIENCE OF Replication-Competent Adenovirus Vectors as Vehicles for HIV Vaccine Delivery Marjorie Robert-Guroff
February 10, 2008 DNA Replication and Recombination Architecture of Replication and Recombination Complexes Fred Dyda
Workshop 5: New Polymerases Kyungjae Myung
Genome Stability and DNA Repair, Alternative Polymerases, DSB Repair Roger Woodgate
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis Matriptase and its inhibitors - balancing cell surface proteolysis during tissue morphogenesis and cancer Roman Szabo
Late Breaking Hot Topics from Abstracts Thomas H Bugge
Reengineering bacterial cytotoxins for protease imaging and tumor targeting Thomas H Bugge
February 7, 2008 Cell Death and Cellular Senescence Cell Death and Cellular Homeostasis (Joint) Michael J. Lenardo
Lymphocyte Activation, Tolerance, and Survival Richard M. Siegel
February 3, 2008 Regulatory Mechanisms in Eukaryotic Transcription Basic Transcriptional Mechanisms Karen Adelman
Nuclear Organization and Transcription Gordon L. Hager
January 13, 2008 Leukocyte Trafficking Lipids and Novel Modulators of Leukocyte Traffic (Joint) Joost J. Oppenheim
January 13, 2008 Chemokines and Chemokine Receptors In Situ Visualization of Lymphocyte Migration and Activation (Joint) Ronald N. Germain
Workshop 1: Chemokine Immunobiology and Signaling Ji-Liang Gao
The Chemokine System in Adaptive Immunity Joshua M. Farber
Tuning Chemokines in Inflammation John H Kehrl
Lipids and Novel Modulators of Leukocyte Traffic (Joint) Joost J. Oppenheim
Workshop 2: Chemokines in Pathology and Therapy Jean K. Lim
January 13, 2008 Forkhead Transcription Factor Networks in Development, Signaling, and Disease Metabolism and Signaling R McKay
December 1, 2007 47TH American Socieity of Cell Biology Membrane Dynamics Jennifer Lippincott-Schwartz
The C-terminal Extension of hCenexin1 Is Critical for Proper Recruitment and Mitotic Functions of Mammalian Polo-like L. Yu, T. Veenstra
Adhesions and Myosins (Room 204 A/B) Robert S Adelstein
Cell Matrix Interactions (Room 140A) Kenneth. M. Yamada
Advances in Bone Cell Molecular Biology: Epigenetic Control Michael Bustin, Gordon L. Hager
Cellular Biology of Gap Junction Channels (Room 103A) Richard Francis
High Performance Image Analysis and Photomanipulative Techniques for Gordon L. Hager
Dynamics of Rafts, Stabilized Rafts, and Other Non-Raft Domains of Jennifer Lippincott-Schwartz
The NCI Alliance for Nanotechnology in Cancer: Creating Next Piotr Grodzinski
Seeing in The Dark: How Fluorescent Proteins Are Shaping Biology Jennifer Lippincott-Schwartz
Lamin A-dependent Misregulation of Adult Stem Cells Associated with Accelerated Aging. T Misteli
The Arf1 GAP Centaurin Gamma-2/AGAP1 Modulates Neuronal Differentiation. P Randazzo
VEGF Controls Endothelial Cell Permeability by the Endocytosis of VE-cadherin J. Silvio Gutkind,
Understanding the Cell Migration Engine Using High-Resolution Quantitative Light Microscopy Clare M Waterman
A Molecular Mechanism for Aging-related Loss of Heterochromatin and DNA Damage. G Pegoraro, T Misteli
NSBP1: A Novel Protein Which Binds Specifi cally to Nucleosome in Euchromatin and Affects Cellular Differentiation. M Rochman, Michael Bustin
Global Interactions of the Glucocorticoid Receptor Require Extensive Chromatin Remodeling. M Sung, S. John, T A Johnson, P S Meltzer, J Stamatoyannopoulos, Gordon L. Hager
Supported by Merck Research Laboratories:RNA Silencing Mechanisms Natasha J Caplen
Applications of RNAi Screens in the Study of Cancer-associated Processes John N Weinstein, Natasha J Caplen, K Huppi
Intercellular Transfer as a Mechanism of Cell Communication within the Hematopoietic Progenitor Niche. Jennifer M Gillette, Jennifer Lippincott-Schwartz
Role of Mitochondrial Remodeling in Programmed Cell Death in Drosophila melanogaster Richard Youle, B Fell
G1 to S Phase Cell Cycle Progression Requires a Single Electrically-coupled Mitochondrial Network with a Continuous Kasturi Mitra, Jennifer Lippincott-Schwartz
Analysis of Myosin II-induced Maturation of Focal Adhesions. Clare M Waterman
Vesicular Traffi cking and Protein Synthesis Are Required for Streaming during Chemotaxis Carole A Parent, Guofeng Zhang, Paul W Kriebel, Valarie A Barr
Mechanisms of Membrane Traffi cking Juan S Bonifacino
The Complexity of Phosphorylated H2AX Foci and DNA Repair Protein Assembly at DNA Double-stranded Breaks William M Bonner
Structural Analysis of Dynamin Family Members Offers Insight into Membrane Fission Jason A Mears
The AP4 Complex Mediates Sorting of the Amyloid Precursor Protein at the trans-Golgi Network Juan S Bonifacino
Actin Dynamics Regulate a Biophysical Maturation Switch in Focal Adhesions. Clare M Waterman
Effects of O-GlcNAcase on Insulin Signaling in Adipocytes D. Love
November 15, 2007 Genostem 2007 Mesenchymal Stem Cells Plasticity and transdifferentiation Rocky S. Tuan
November 4, 2007 2007 International Symposium On Protein Modification And Degradation Ubiquitin ligase machinery: From plant biology to human diseases Allan Weissman
November 3, 2007 Neuroscience 2007 37th annual meeting of the Society for Neuroscience Careers for Neuroscientists Leslie G Ungerleider
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) TECHnology Platform EXPO (08:25-12:00) Meredith Yeager
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Meredith Yeager
Genome Resequencing for Mutation Screening (13:30-18:30) Meredith Yeager
Genome Resequencing for Mutation Screening: Common Variation at 8q24 and Prostate Cancer Risk (17:00-17:30) Meredith Yeager
Bioinformatics (15:30-17:30) Elliott H. Margulies
Bioinformatics: ENCODE Pilot Project and the Future of Comparative Sequence Analysis (17:00-17:30) Elliott H. Margulies
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) John Cidlowski
NUCLEAR HORMONE RECEPTORS: Glucocorticoid Receptors: Old Targets that Need New Drugs (14:45-15:15) John Cidlowski
DISCOVERY CHEMISTRY (08:35-12:55) William T. Schrader
DISCOVERY CHEMISTRY: Chairperson’s Remarks (08:35-08:40) William T. Schrader
INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS (13:55-17:10) William T. Schrader
INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS: Chairperson’s Remarks (13:55-14:00) William T. Schrader
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi Targets and Cancer Biology: Applications of RNAi Screens in the Study of Cancer-associated Processes (11:40-12:10) Natasha J Caplen
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) Managing Data (09:30-12:30) Richard A. Lempicki
Managing Data: Decipher Biologic Pathways and Determine the Total “Omic” Picture with an Integrated DAVID Knowledgebase (09:35-10:05) Richard A. Lempicki
TECHnology Platform EXPO (08:25-12:00) Meredith Yeager
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Meredith Yeager
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Jill Heemskerk
SCREENING AGAINST MULTIPLE TARGETS: Ceftriaxone and Results of Large Scale Screening Efforts (16:15-16:45) Jill Heemskerk
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Jill Heemskerk
SCREENING AGAINST MULTIPLE TARGETS: Ceftriaxone and Results of Large Scale Screening Efforts (16:15-16:45) Jill Heemskerk
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS: Decipher and Select the Genomic Biomarkers with the DAVID Bioinformatics Resources (17:30-18:00) Richard A. Lempicki
Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS (16:00-18:00) Richard A. Lempicki, Brian Luke
Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS: Comparing Fingerprint-based and Biomarker-based Classifiers (16:00-16:30) Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS: Comparing Fingerprint-based and Biomarker-based Classifiers (16:00-16:30) Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS (16:00-18:00) Richard A. Lempicki, Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS: Decipher and Select the Genomic Biomarkers with the DAVID Bioinformatics Resources (17:30-18:00) Richard A. Lempicki
August 5, 2007 Assembly of the Mitochondrial Respiratory Chain Tumor suppressor p53 regulation of complex IV Paul Hwang
July 28, 2007 Lipid Droplets: Metabolic Consequences of the Storage of Neutral Lipids Discovery of an organelle Constantine Londos
Oxysterol binding protein homologs: promoters of interorganellar contacts Timothy A Schulz
July 21, 2007 Hematopoietic Malignancies A cell-cycle independent function of tumor suppressor Ink4b in regulation of lineage choice” Linda Wolff
The ability of CBFβ-SMMHC to repress RUNX1 does not correlate with its ability to induce leukemia Paul Liu
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma Christina Annunziata
DNA damage and oncogenic stress: barriers to chromosomal translocations Andre Nussenzweig
July 7, 2007 LYMPHOCYTES AND THE IMMUNE SYSTEM: Molecular, Cellular and Integrative Mechanisms Targeting V(D)J recombination through promoter activation and germline transcription Ranjan Sen
Integration of T cell signals: lessons from primary immunodeficiencies Pam Schwartzberg
Intravital imaging of immune cell trafficking: control of lymphocyte migration by chemical and physical signals Marc Bajenoff
Germline N-Ras mutation causes a human lymphoproliferative syndrome Michael J. Lenardo
June 23, 2007 Signal Transduction in the Immune System Viewing the initiation of B cell receptor signaling in living cells Susan K. Pierce
Lipid kinases and phosphatases in the regulation of IgE/Fc epsilon homeostasis and function Juan Rivera
“Integrating T cell signals Pam Schwartzberg
“Cytokine signaling and new paradigms in helper/effector cell differentiation John O’Shea
Signaling at the TCR and the effect on calcium regulation Lawrence Samelson
Germline N-Ras mutation causes a human lymphoproliferative syndrome Michael J. Lenardo
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Immune Cell Function David D Roberts
Therapeutic Applications David D Roberts
Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts Jeff S Isenberg
June 9, 2007 Mitosis: Spindle Assembly and Function Moonlighting in mitosis: Nucleoporins at kinetochores Mary Dasso
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease ABC Transporters-Evolution, Variation and Human Disease Michael Dean
Synonymous mutations affect function of the multidrug transporter Suresh Ambudkar
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.